Skip to main content
Top
Published in: Calcified Tissue International 5/2013

01-05-2013 | Letter to The Editor

Intermittent High Doses of Vitamin D: A Need for Further Studies?

Authors: Salvatore Minisola, Luciano Colangelo, Mirella Cilli, Cristiana Cipriani, Jessica Pepe, Elisabetta Romagnoli

Published in: Calcified Tissue International | Issue 5/2013

Login to get access

Excerpt

It was with interest that we read the paper by Sanders et al. [1] enlightening the harmful effects of the administration of huge doses of vitamin D. However, we believe that some points need clarification. …
Literature
1.
go back to reference Sanders KM, Nicholson GC, Ebeling PR (2013) Is high dose vitamin D harmful? Calcif Tissue Int 92:191–206PubMedCrossRef Sanders KM, Nicholson GC, Ebeling PR (2013) Is high dose vitamin D harmful? Calcif Tissue Int 92:191–206PubMedCrossRef
2.
go back to reference Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trial. JAMA 303:1815–1822PubMedCrossRef Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trial. JAMA 303:1815–1822PubMedCrossRef
3.
go back to reference Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46:1815–1822 Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46:1815–1822
4.
go back to reference Vieth R (2011) The pharmacology of vitamin D. In: Feldman D, Pike J, Adams J (eds) Vitamin D. Academic Press, London, pp 1041–1066CrossRef Vieth R (2011) The pharmacology of vitamin D. In: Feldman D, Pike J, Adams J (eds) Vitamin D. Academic Press, London, pp 1041–1066CrossRef
5.
go back to reference Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V et al (2010) Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 95:4771–4777PubMedCrossRef Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V et al (2010) Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 95:4771–4777PubMedCrossRef
6.
go back to reference Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E et al (2008) Short- and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 93:3015–3020PubMedCrossRef Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E et al (2008) Short- and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 93:3015–3020PubMedCrossRef
Metadata
Title
Intermittent High Doses of Vitamin D: A Need for Further Studies?
Authors
Salvatore Minisola
Luciano Colangelo
Mirella Cilli
Cristiana Cipriani
Jessica Pepe
Elisabetta Romagnoli
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 5/2013
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9714-x

Other articles of this Issue 5/2013

Calcified Tissue International 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.